Model
Edge
Alnylam Pharmaceuticals, Inc.
0001661908
Filing type
4
Filing date
May 21, 2026
Updated
May 22, 2026 ยท 2:20 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership